Skip to main content
All lobbying filings

Bell & Lindsay, Inc.

Bell & Lindsay, Inc. filed a Q4 report for OYE Therepeutics on February 11, 2026, reporting $10,000 in lobbying income.

Lobbying for OYE Therepeutics · Pharmaceutical, development stage, company

As filed: BELL & LINDSAY, INC. for OYE THEREPEUTICS.

All filings by Bell & Lindsay, Inc. · Everything OYE Therepeutics has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Feb 11, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Indiana

Official filing document

 Lobbyists on this filing 1
  • MARK F LINDSAY
    Previously held: US House Staff

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 9

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem